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Abstract
Recently, several studies have been performed to better outline the pathophysiology of acute
respiratory failure and evaluate the therapeutic profile of different modes of ventilation and ventilator
settings. Here we briefly report those we consider most relevant for daily intensive care unit clinical
practice.
Introduction and context
The optimization of ventilatory support is a crucial
issue in the management of patients with acute
respiratory failure, aiming at improving gas exchange
and patient-ventilator interaction while preventing
ventilator-induced dysfunction of the respiratory system.
Recent advances
A very important study by Levine et al. [1] shows in
humans, as previously observed in animal models, that
the combination of diaphragm inactivity and mechan-
ical ventilation is associated with marked diaphragm
atrophy. Diaphragm atrophy, which may occur after just
18 hours of controlled mechanical ventilation as a result
of increased myofibril proteolysis, may contribute to
prolongation and/or failure of the weaning process. This
study, performed in brain-dead organ donors, underlines
the importance of using modes of partial ventilatory
support whenever possible and not contraindicated, in
order to reduce the time spent on mechanical ventilation
and its side effects.
Relevant clinical research has investigated the complex
interaction between patient and ventilator during partial
support. Thille et al. [2] compared three different
strategies conventionally aimed to optimize patient-
ventilator interaction in pressure support ventilation
(PSV): reduction of support level, reduction of insuffla-
tion time and application of positive end-expiratory
pressure (PEEP). The reduction of pressure support
succeeded in eliminating ineffective triggering in two-
thirds of the patients without increasing the work of the
respiratory muscles or altering gas exchange, while the
effects of reducing insufflation time and increasing PEEP
were less important and not significant. The improve-
ment in patient-ventilator synchrony becomes relevant
when tidal volume (VT) is reduced to 6 ml/kg, which is
therefore suggested by the authors as a target for
adjustment of inspiratory pressure support level.
Neurally adjusted ventilatory assist (NAVA) is a new
form of partial support wherein the ventilator applies
positive pressure throughout inspiration in proportion
to the electrical activity of the diaphragm, as assessed by
transoesophageal electromyography. Allowing ventilator
functioning and cycling to be under direct control of the
patient's respiratory drive and rhythm, NAVA aims to
enhance patient-ventilator interaction and minimize the
risk of over-assistance. A recent study by Colombo et al.
[3] compares the physiological response to different
levels of assistance delivered with NAVA and PSV. As
opposed to NAVA, PSV was prone to the risk of
over-assistance, as identified by higher VT, significant
mismatch between neural and flow-based timing and
frequent occurrence of ineffective efforts. The study
indicates that, compared to PSV, NAVA has the
potential to limit the risk of over-assistance, prevent
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patient-ventilator interaction.
Two recent trials have evaluated the impact of different
ventilator settings in the prevention of ventilator-
induced lung injury (VILI) in patients with acute lung
injury and acute respiratory distress syndrome (ARDS).
Meade et al. [4] compared the effects of a ventilatory
strategy combining low VT, recruitment manoeuvres and
high levels of PEEP with the established ventilatory
strategy. In the experimental group, VT was set at 6 ml/kg,
with plateau airway pressures (Paw-plateau) <40 cmH2O.
Each trial started with a 40-second breath-hold at
40 cmH2OP aw recruitment manoeuvre on a fraction of
inspired oxygen (FiO2) of 1.0, which could be repeated
up to four times daily. The control group underwent the
ARDS Network ventilation protocol (volume-assist
control mode, VT 6 ml/kg and Paw-plateau <30 cmH2O,
with PEEP determined according to FiO2, no recruitment
manoeuvre). Results showed a significant difference in
PEEP levels associated with lower incidence of hypox-
emia and FiO2 requirement, less recourse to rescue
oxygenation therapies, and fewer deaths due to refractory
hypoxemia in the intervention group, as opposed to
the control group, while no significant difference in
mortality rate and duration of mechanical ventilation
was found.
Mercat et al. [5] evaluated a strategy using high PEEP
levels to increase alveolar recruitment while avoiding
excessive hyperinflation by limiting Paw-plateau and using
low VT. In the control group, Paw-plateau was kept as low as
possible without falling below oxygenation targets,
setting PEEP between 5 and 9 cmH2O. In the experi-
mental group, PEEP was adjusted based on Paw and kept
as high as possible without increasing Paw-plateau above
28–30 cmH2O, regardless of its effects on oxygenation.
The experimental strategy significantly improved oxyge-
nation and respiratory system compliance and reduced
the time spent on mechanical ventilation and with organ
failures, but failed to reduce mortality.
In an intriguing study, Chiumello et al. [6] consider VILI
a result of excessive lung stress and strain, as assessed by
transpulmonary pressure and inflated volume to func-
tional residual capacity ratio, respectively. As stress and
strain cannot be measured in clinical practice, the study
aims to determine the accuracy at which the two
parameters can be inferred by analyzing their commonly
utilized surrogates, that is, Paw-plateau and VT/kg. Cur-
rently, prevention of VILI is based on recognizing the
harmful threshold for these surrogates, identified as
28–30 cmH2O( P aw-plateau) and 6 ml/kg (VT/kg). In a
varied population ranging from postoperative patients
with intact lung function to patients with ARDS,
Paw-plateau and VT did not prove to be adequate surrogates
for lung stress and strain. Interestingly, the stress to strain
relationship was the same in all the subgroups, being
linear in the ranges of pressures and volumes explored.
The specific lung elastance was also similar in the
various subgroups, remaining constant at approximately
13.5 cmH2O, regardless of ventilator settings. Because
stress and strain were demonstrated to be linked by a
constant proportionality factor, that is, the specific lung
elastance, stress can be calculated as 13.5 cmH2O × strain.
As a strain greater than 2, corresponding to an
end-inspiratory lung volume in the range of total lung
capacity, has been identified as critical for the risk of
development of lung injury, the harmful threshold of
stress will consequently be 2 × 13.5 cmH2O; therefore
the recommended Paw-plateau threshold of 28–30 cmH2O
seems reasonable for most acute lung injury/ARDS
patients.
Implications for clinical practice
The identification of diaphragmatic atrophy after just
18 hours of controlled mechanical ventilation suggests
the importance of adopting modes of partial ventilatory
support as soon as possible. The optimization of patient-
ventilator synchrony should be based either on the
reduction of the assistance provided with the commonly
used modes of partial support or on the application of
new forms of mechanical assistance designed to improve
the interaction between the patient and the ventilator,
such as NAVA.
In patients with ARDS, ventilatory strategies for optimiz-
ing PEEP with the aim of increasing alveolar recruitment
while limiting hyperinflation succeeded in improving
lung function and reducing the duration of mechanical
ventilation, but failed to reduce mortality. The introduc-
tion of the measurement of lung stress and strain into
daily clinical practice could allow a better identification
of the safe limits of mechanical ventilation in the
presence of lung injury.
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